Upgrade to the Zeiss Serial Block Face Scanning Electron Microscope
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH OLAO
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75N98026Q00902 in this department, oldest first.
- Jul 29, 2026 · this noticePre-solicitation
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
Authority: FAR 6.302-1 � Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements Contracting Activity: National Institute of Biomedical Imaging and Bioengineering (NIBIB) Proposed Contractor: Carl Zeiss Description of Requirement This is an upgrade to the Zeiss Serial Block Face Scanning Electron Microscope. This instrument is used to study the three-dimensional structure of cells and tissues using the serial block face (SBF) imaging technique using an ultramicrotome built into the specimen chamber of the SEM. Justification for Sole Source NIBIB intends t… (show all)
o negotiate and award a sole source contract to Carl Zeiss pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. The proposed upgrade is for an existing Zeiss Serial Block Face Scanning Electron Microscope (SBF-SEM) manufactured by Carl Zeiss AG. This upgrade must be carried out by the original equipment manufacturer because: 1. Proprietary Technology o The upgrade involves proprietary hardware, software, firmware, and system integration developed exclusively by Carl Zeiss. o The technical specifications, source code, calibration procedures, and engineering documentation necessary to perform the upgrade are not available to third-party vendors. 2. System Compatibility o The microscope is an integrated instrument whose imaging performance depends on precise compatibility between the microscope hardware, detectors, stage controls, software, and Serial Block Face system. o Only Carl Zeiss can ensure that the upgraded components are fully compatible with the existing instrument configuration. 3. Factory Calibration and Validation o Following installation, the upgraded system requires factory-approved calibration, alignment, and performance verification to meet manufacturer specifications. o These procedures require proprietary service tools, software, and trained factory-certified engineers. 4. Preservation of Warranty and Service Support o Installation by any non-authorized organization could invalidate manufacturer warranties, future service agreements, software support, or eligibility for future upgrades. o Carl Zeiss maintains responsibility for continued maintenance, software updates, and technical support of the upgraded system. 5. No Equivalent Alternative o No other vendor has the legal authority, proprietary knowledge, or access to OEM components necessary to provide an equivalent upgrade while maintaining the instrument's specified performance. o Third-party service providers cannot supply genuine Zeiss upgrade kits or certify the system to manufacturer performance specifications. 6. Research Continuity o The upgraded system must maintain continuity with existing research protocols, imaging workflows, and previously acquired datasets. o Using the OEM upgrade minimizes downtime and reduces technical risks that could negatively affect ongoing research. Notice to Interested Parties This notice is not a request for competitive quotations or proposals. However, any responsible source, including small businesses, 8(a) firms, HUBZone small businesses, service-disabled veteran-owned small businesses (SDVOSBs), women-owned small businesses (WOSBs), veteran-owned small businesses (VOSBs), and small disadvantaged businesses (SDBs), may submit a capability statement demonstrating its ability to satisfy the Government's requirement. Capability statements will be evaluated solely to determine whether a competitive procurement should be conducted. A determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the Government's discretion. Anticipated Award The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice unless the Government determines that another responsible source is capable of satisfying the Government's requirements. Capability statements must be submitted via email to haunp@mail.nih.gov no later than 9:00 a.m. EDT on August 7, 2026.
Who won similar work
10 award notices on SAM.gov in the last 24 months. Matched by: Same office (NATIONAL INSTITUTES OF HEALTH OLAO), same product/service code (PSC) 6640 and NAICS 334516.
Single-winner award sizes (10): middle half $37K to $188K, median $61K; range $21K to $230K.
| Winner | Awards | Value | Last |
|---|---|---|---|
| BRUKER NANO, INC · $BRKR · $3.0B | 1 | $230K | Aug 14, 2026 |
| Sony Biotechnology Inc. | 1 | $227K | Aug 17, 2026 |
| NEWPORT CORP | 1 | $212K | Jul 8, 2026 |
| AMUZA INC. | 1 | $115K | Jul 10, 2026 |
| PARSE BIOSCIENCES, INC. | 1 | $67K | Jul 8, 2026 |
| Mirion Technologies (Capintec), Inc. | 1 | $56K | Jun 29, 2026 |
| NIKON INSTRUMENTS INC | 1 | $40K | Sep 25, 2026 |
| SR RESEARCH LIMITED | 1 | $37K | Jul 8, 2026 |
| BECKMAN COULTER, INC | 1 | $31K | Jul 10, 2026 |
| Revvity Health Sciences, Inc. | 1 | $21K | Oct 9, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $BRKR reported $3.0B revenue in FY2025. The median single-winner award in these 10 past awards, $61K, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 9, 2026Revvity Health Sciences, Inc.$21KAutomated Cell Counter and Analyzer
- Sep 25, 2026NIKON INSTRUMENTS INC$40K66--Warming Box/Enclosure for Nikon Eclipse Ti-2 AX co
- Aug 17, 2026Sony Biotechnology Inc.$227K66--NIMH: Purchase order for One (1) Microfluidic Base
- Aug 14, 2026BRUKER NANO, INC$230K66--NIMH: Purchase order for One (1) Miniaturized Head
- Jul 10, 2026AMUZA INC.$115K66--NIMH: Purchase order for four (4) wireless fiber p
- Jul 10, 2026BECKMAN COULTER, INC$31K66--Purchase Order for two (2) Hematology Analysers
- Jul 8, 2026SR RESEARCH LIMITED$37K66--NIMH: Purchase Order for One (1) EyeLink 1000 Plus
- Jul 8, 2026NEWPORT CORP$212K66--RFQ for One (1) Tunable Laser Multi-Photon Microsc
- Jul 8, 2026PARSE BIOSCIENCES, INC.$67K66--PO for One (1) Evercode WT v3 with UDI Plate and
- Jun 29, 2026Mirion Technologies (Capintec), Inc.$56K66--PO Three(3) Capintec CRC-55tr Dose Calibrator Syst
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
- 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.